Beskrivning
| Land | Norge |
|---|---|
| Lista | Oslo Bors |
| Sektor | Handel & varor |
| Industri | Dagligvaror |
2024-10-30 16:06:52
Aker BioMarine will release the third quarter 2024 results on Friday 1 November
2024 at 07:00 CET. At 09:00 CET on the same day, the management will host a
webcast to present the results.
The webcasted presentation will be in English. To join, please use the link that
will be available at www.akerbiomarine.com/investor.
A replay of the presentation will be made available soon after the presentation
at the same web page.
For further information, please contact
Christopher Robin Vinter, VP Strategic Finance & IR
Mobile: +47 911 60 820
Email: christopher.vinter@akerbiomarine.com
About Aker BioMarine
Aker BioMarine is a leading human health and nutrition innovator that develops
krill-derived products for consumer health and nutrition. Krill is a natural,
powerful, and health-promoting source of nutrients from the pristine waters of
Antarctica, and Aker BioMarine has a unique position in its industry. The
ingredient portfolio consists of Superba Krill Oil, Lysoveta, FloraMarine, and
PL+, as well as the consumer brand, Kori Krill. The innovative approach also
extends into the spin-offs AION (reduce and recycle plastic waste across
industries) and Understory (a protein brand). Aker BioMarine is listed on the
Oslo Stock Exchange (AKBM). More information is available at
www.akerbiomarine.com.